Site‐ and Stage‐Adapted Treatment Strategies for Gastrointestinal Diffuse Large B‐Cell Lymphoma
Gastrointestinal diffuse large B-cell lymphoma had survival outcomes comparable to those of non-GI-DLBCL, suggesting site- and stage-specific therapies may confer a survival benefit.
Authors
- Tatsu Shimoyama
- Mao Matsubayashi (ORCID: https://orcid.org/0000-0002-9750-8841)
- Atsushi Takahara (ORCID: https://orcid.org/0000-0002-0584-1525)
- Yudai Hayashi (ORCID: https://orcid.org/0009-0009-2539-6316)
- Kazushige Kawai (ORCID: https://orcid.org/0000-0002-5881-0036)
- Yasuhiko Yamamura
- Taichi Tamura (ORCID: https://orcid.org/0009-0007-0472-2050)
- HARUHIKO CHO
- Takuya Shimizuguchi (ORCID: https://orcid.org/0000-0001-9763-0743)
- Kento Ishimine
- Toshihiro Okuya
- Yusuke Kanemasa (ORCID: https://orcid.org/0000-0002-9809-2008)
- Kaho Fujino
- Mano Mino
- Shinichiro Matsuda
- Shohei Nakamura (ORCID: https://orcid.org/0000-0001-6386-500X)
- Yu Yagi
- Yuki Sasaki (ORCID: https://orcid.org/0000-0002-1953-4366)
- Kumiko Fujita
- Taiga Kuga
- Naoki Kanai
- Yusuke Masuda
Institutions
- Tokyo Metropolitan Komagome Hospital (JP)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1111/ejh.14440
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00